These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9871690)

  • 1. Synthesis of Dolastatin 15 mimetic peptoids.
    Schmitt J; Bernd M; Kutscher B; Kessler H
    Bioorg Med Chem Lett; 1998 Feb; 8(4):385-8. PubMed ID: 9871690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antineoplastic agents 365. Dolastatin 10 SAR probes.
    Pettit GR; Srirangam JK; Barkoczy J; Williams MD; Boyd MR; Hamel E; Pettit RK; Hogan F; Bai R; Chapuis JC; McAllister SC; Schmidt JM
    Anticancer Drug Des; 1998 Jun; 13(4):243-77. PubMed ID: 9627667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and X-ray crystal structure of the dolabellaauricularia peptide dolastatin 18.
    Pettit GR; Hogan F; Herald DL
    J Org Chem; 2004 Jun; 69(12):4019-22. PubMed ID: 15176826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dolastatin 11, a marine depsipeptide, arrests cells at cytokinesis and induces hyperpolymerization of purified actin.
    Bai R; Verdier-Pinard P; Gangwar S; Stessman CC; McClure KJ; Sausville EA; Pettit GR; Bates RB; Hamel E
    Mol Pharmacol; 2001 Mar; 59(3):462-9. PubMed ID: 11179440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition of human lymphoma cell lines by the marine products, dolastatins 10 and 15.
    Beckwith M; Urba WJ; Longo DL
    J Natl Cancer Inst; 1993 Mar; 85(6):483-8. PubMed ID: 8445676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total synthesis and biological activity of dolastatin 16.
    Casalme LO; Yamauchi A; Sato A; Petitbois JG; Nogata Y; Yoshimura E; Okino T; Umezawa T; Matsuda F
    Org Biomol Chem; 2017 Feb; 15(5):1140-1150. PubMed ID: 28074955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineoplastic agents 337. Synthesis of dolastatin 10 structural modifications.
    Pettit GR; Srirangam JK; Barkoczy J; Williams MD; Durkin KP; Boyd MR; Bai R; Hamel E; Schmidt JM; Chapuis JC
    Anticancer Drug Des; 1995 Oct; 10(7):529-44. PubMed ID: 7495477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and cytostatic properties of structure-simplified analogs of dolastatin 15.
    Hu MK; Huang WS
    J Pept Res; 1999 Dec; 54(6):460-7. PubMed ID: 10604591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay.
    Aherne GW; Hardcastle A; Valenti M; Bryant A; Rogers P; Pettit GR; Srirangam JK; Kelland LR
    Cancer Chemother Pharmacol; 1996; 38(3):225-32. PubMed ID: 8646796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1.
    Mohammad RM; Varterasian ML; Almatchy VP; Hannoudi GN; Pettit GR; Al-Katib A
    Clin Cancer Res; 1998 May; 4(5):1337-43. PubMed ID: 9607595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiproliferative activity of a cyclic analog of dolastatin 10.
    Poncet J; Hortala L; Busquet M; Guéritte-Voegelein F; Thoret S; Pierré A; Atassi G; Jouin P
    Bioorg Med Chem Lett; 1998 Oct; 8(20):2855-8. PubMed ID: 9873636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects of cellular microtubules.
    Bai R; Friedman SJ; Pettit GR; Hamel E
    Biochem Pharmacol; 1992 Jun; 43(12):2637-45. PubMed ID: 1632820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antineoplastic agents 360. Synthesis and cancer cell growth inhibitory studies of dolastatin 15 structural modifications.
    Pettit GR; Flahive EJ; Boyd MR; Bai R; Hamel E; Pettit RK; Schmidt JM
    Anticancer Drug Des; 1998 Jan; 13(1):47-66. PubMed ID: 9474242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and structure of the human cancer cell growth inhibitory cyclodepsipeptide dolastatin 16.
    Pettit GR; Xu JP; Hogan F; Williams MD; Doubek DL; Schmidt JM; Cerny RL; Boyd MR
    J Nat Prod; 1997 Aug; 60(8):752-4. PubMed ID: 9287413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineoplastic Agents. 603. Quinstatins: Exceptional Cancer Cell Growth Inhibitors.
    Pettit GR; Melody N; Chapuis JC
    J Nat Prod; 2017 Mar; 80(3):692-698. PubMed ID: 28211277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antitumor activity of novel dolastatin 10 analogs.
    Miyazaki K; Kobayashi M; Natsume T; Gondo M; Mikami T; Sakakibara K; Tsukagoshi S
    Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1706-18. PubMed ID: 8536345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineoplastic agents. 592. Highly effective cancer cell growth inhibitory structural modifications of dolastatin 10.
    Pettit GR; Hogan F; Toms S
    J Nat Prod; 2011 May; 74(5):962-8. PubMed ID: 21534541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1.
    Luesch H; Moore RE; Paul VJ; Mooberry SL; Corbett TH
    J Nat Prod; 2001 Jul; 64(7):907-10. PubMed ID: 11473421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dolastatins, a family of promising antineoplastic agents.
    Poncet J
    Curr Pharm Des; 1999 Mar; 5(3):139-62. PubMed ID: 10066887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity of chimeric structures derived from the cytotoxic natural compounds dolastatin 10 and dolastatin 15.
    Poncet J; Busquet M; Roux F; Pierré A; Atassi G; Jouin P
    J Med Chem; 1998 Apr; 41(9):1524-30. PubMed ID: 9554885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.